Europe Influenza Diagnostics Market Size & Outlook

The influenza diagnostics market in Europe is expected to reach a projected revenue of US$ 731.3 million by 2030. A compound annual growth rate of 5.9% is expected of Europe influenza diagnostics market from 2024 to 2030.
Revenue, 2023 (US$M)
$489.1
Forecast, 2030 (US$M)
$731.3
CAGR, 2024 - 2030
5.9%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe influenza diagnostics market, 2018-2030 (US$M)

Europe influenza diagnostics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe influenza diagnostics market highlights

  • The Europe influenza diagnostics market generated a revenue of USD 489.1 million in 2023.
  • The market is expected to grow at a CAGR of 5.9% from 2024 to 2030.
  • In terms of segment, ridt was the largest revenue generating test type in 2023.
  • RIDT is the most lucrative test type segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.

Europe data book summary

Market revenue in 2023USD 489.1 million
Market revenue in 2030USD 731.3 million
Growth rate5.9% (CAGR from 2023 to 2030)
Largest segmentRidt
Fastest growing segmentRIDT
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationRIDT, RT-PCR, Cell Culture
Key market players worldwide3M Co, Abbott Laboratories, Becton Dickinson & Co, Meridian Bioscience, QuidelOrtho Corp, Roche Holding AG, Sekisui Chemical Co Ltd, Thermo Fisher Scientific Inc, Hologic Inc, SA Scientific

Other key industry trends

  • In terms of revenue, Europe region accounted for 29.9% of the global influenza diagnostics market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 719.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Influenza Diagnostics Market Companies

Name Profile # Employees HQ Website
SA Scientific View profile 51-100 San Antonio, Texas, United States, North America http://www.sascientific.com
Sekisui Chemical Co Ltd View profile 26838 4-4, Nishitenma 2-Chome, Kita-ku, Osaka, Japan, 530-8565 http://www.sekisui.co.jp
Meridian Bioscience View profile 501-1000 Cincinnati, Ohio, United States, North America http://meridianbioscience.com
Hologic Inc View profile 6990 250 Campus Drive, Marlborough, MA, United States, 01752 http://www.hologic.com
QuidelOrtho Corp View profile 7100 9975 Summers Ridge Road, San Diego, CA, United States, 92121 https://www.quidelortho.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
3M Co View profile 85000 3M Center, St. Paul, MN, United States, 55144 https://www.3m.com
Becton Dickinson & Co View profile 73000 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 https://www.bd.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

Europe influenza diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to influenza diagnostics market will help companies and investors design strategic landscapes.


Ridt was the largest segment with a revenue share of 30.89% in 2023. Horizon Databook has segmented the Europe influenza diagnostics market based on ridt, rt-pcr, cell culture covering the revenue growth of each sub-segment from 2018 to 2030.


  • Europe Influenza Diagnostics Test Type Outlook (Revenue, USD Million, 2018-2030)
    • RIDT
    • RT-PCR
    • Cell Culture
    • Others
  • Europe Influenza Diagnostics End Use Outlook (Revenue, USD Million, 2018-2030)
    • Hospitals
    • POCT
    • Laboratories

Reasons to subscribe to Europe influenza diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe influenza diagnostics market databook

  • Our clientele includes a mix of influenza diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe influenza diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe influenza diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe influenza diagnostics market size, by country, 2018-2030 (US$M)

Europe Influenza Diagnostics Market Outlook Share, 2023 & 2030 (US$M)

Europe influenza diagnostics market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online